Evidence map›Paper›PMID 12915544›Full record

ArticleJournal of virology2003

Human cytomegalovirus US2 causes similar effects on both major histocompatibility complex class I and II proteins in epithelial and glial cells.

Nagendra R Hegde, David C Johnson

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Frontiers in cellular and infection microbiology · 2020
    Article
  4. Review
  5. Review
  6. CD4 CTL: living up to the challenge.Seminars in immunology · 2013
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Nagendra R HegdeDepartment of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon 97239-3098, USA.
David C Johnson
Oregon Health & Science University · US

Funding

INHIBITION OF CLASS I ANTIGEN PRESENTATION BY HSV ICP47R01EY011245 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI JOHNSON, DAVID C. · 1996 to 2008
$3.6M
TRANSMISSION OF HERPES SIMPLEX ACROSS CELL JUNCTIONSR01CA073996 · NCI · OREGON HEALTH AND SCIENCE UNIVERSITY · PI JOHNSON, DAVID · 1998 to 2002
$721k
NCI NIH HHS CA73996NCI NIH HHS R01 CA073996NEI NIH HHS EY11245NEI NIH HHS R01 EY011245
6 · The paper itself

Abstract

The human cytomegalovirus (HCMV) glycoprotein US2 specifically binds to major histocompatibility complex (MHC) class I heavy chain (HC) and class II proteins DRalpha and DMalpha, triggering their degradation by proteasomes. Effects of US2 on class II proteins were originally characterized in HCMV- or adenovirus vector-infected U373 astroglioma cells. Here, we have extended characterization of US2-mediated degradation of class II DRalpha to two other cell lines, including biologically relevant epithelial cells. Comparison of the effects of US2 in cells expressing both class I and II proteins demonstrated only a slight preference for class I HC. Moreover, US2 caused degradation of DRalpha and DMalpha when these proteins were expressed by transfection without DRbeta, invariant chain (Ii), or DMbeta. Therefore, US2 binds to alpha chains of DR and DM and triggers endoplasmic reticulum degradation without formation of class II DR alphabeta/Ii or DM alphabeta complexes. Similar levels of degradation of class II alpha were observed in cells expressing vastly different amounts of class II, suggesting that cellular factors, other than class II, were limiting. We concluded that US2 has broad effects in a variety of cells that express both class I and II proteins and is relevant to HCMV infection in vivo.

Indexed as

AdenoviridaeCell LineCytomegalovirusEpithelial CellsGenetic VectorsHeLa CellsHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHLA-D AntigensHLA-DR AntigensHumansKineticsMembrane GlycoproteinsNeurogliaProtein BindingRecombinant ProteinsHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHLA-D AntigensHLA-DM antigensHLA-DR AntigensMembrane GlycoproteinsRecombinant ProteinsUS2 protein, VaricellovirusViral Envelope ProteinsViral Proteins

Identifiers

PMID12915544
PMCPMC187418
OpenAlexW2115456405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.